Unknown

Dataset Information

0

Combined IL-15 and IL-12 drives the generation of CD34(+)-derived natural killer cells with superior maturation and alloreactivity potential following adoptive transfer.


ABSTRACT: Adoptive transfer of allogeneic natural killer (NK) cells represents a promising treatment approach against cancer, including acute myeloid leukemia (AML). Previously, we reported a cytokine-based culture method for the generation of NK cell products with high cell number and purity. In this system, CD34(+) hematopoietic progenitor cells (HPC) were expanded and differentiated into NK cells under stroma-free conditions in the presence of IL-15 and IL-2. We show that combining IL-15 with IL-12 drives the generation of more mature and highly functional NK cells. In particular, replacement of IL-2 by IL-12 enhanced the cytolytic activity and IFN? production of HPC-NK cells toward cultured and primary AML cells in vitro, and improved antileukemic responses in NOD/SCID-IL2R?null (NSG) mice bearing human AML cells. Phenotypically, IL-12 increased the frequency of HPC-NK cells expressing NKG2A and killer immunoglobulin-like receptor (KIR), which were more responsive to target cell stimulation. In addition, NK15/12 cell products demonstrated superior maturation potential, resulting in >70% positivity for CD16 and/or KIR within 2 weeks after infusion into NSG mice. We predict that higher functionality and faster in vivo maturation will favor HPC-NK cell alloreactivity toward malignant cells in patients, making this cytokine combination an attractive strategy to generate clinical HPC-NK cell products for cancer adoptive immunotherapy.

SUBMITTER: Cany J 

PROVIDER: S-EPMC4485802 | biostudies-other | 2015 Jul

REPOSITORIES: biostudies-other

altmetric image

Publications

Combined IL-15 and IL-12 drives the generation of CD34<sup>+</sup>-derived natural killer cells with superior maturation and alloreactivity potential following adoptive transfer.

Cany Jeannette J   van der Waart Anniek B AB   Spanholtz Jan J   Tordoir Marleen M   Jansen Joop H JH   van der Voort Robbert R   Schaap Nicolaas M NM   Dolstra Harry H  

Oncoimmunology 20150401 7


Adoptive transfer of allogeneic natural killer (NK) cells represents a promising treatment approach against cancer, including acute myeloid leukemia (AML). Previously, we reported a cytokine-based culture method for the generation of NK cell products with high cell number and purity. In this system, CD34<sup>+</sup> hematopoietic progenitor cells (HPC) were expanded and differentiated into NK cells under stroma-free conditions in the presence of IL-15 and IL-2. We show that combining IL-15 with  ...[more]

Similar Datasets

| S-EPMC6717263 | biostudies-literature
| S-EPMC6513806 | biostudies-literature
| S-EPMC5818449 | biostudies-literature
| S-EPMC7006941 | biostudies-literature
| S-EPMC3959288 | biostudies-literature
| S-EPMC6612093 | biostudies-literature
| S-EPMC524066 | biostudies-literature
| S-EPMC4786629 | biostudies-literature
| S-EPMC4792546 | biostudies-literature
| S-EPMC3237743 | biostudies-literature